Inventor profile of:

Stephen L. Hoffman

City:

Gaithersburg, Maryland

Country:

United States

Published Applications:

29

Last publication date:

2025-07-31

Top Assignees for applications by Stephen L. Hoffman

The entities that hold a legal rights for patent applications filed by inventor Hoffman Stephen L.:

Recent patent applications by Hoffman Stephen L.

Stephen L. Hoffman from Gaithersburg, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-07-31
US20250242009A1
Human necessities

INFECTIOUS PLASMODIUM SPOROZOITES GROWN IN VITRO

#2 | 2024-05-30
US20240173393A1
Human necessities

Infectious plasmodium sporozoites grown in vitro

#3 | 2022-10-13
US20220323562A1
Human necessities

LIVE ATTENUATED ORAL VACCINE AGAINST SHIGELLOSIS AND TYPHOID FEVER

#4 | 2022-08-18
US20220257742A1
Human necessities

Infectious sporozoites grown in vitro

#5 | 2022-07-28
US20220233681A1
Human necessities

LIVE ATTENUATED ORAL VACCINE AGAINST COVID-19 AND TYPHOID FEVER

#6 | 2020-12-03
US20200376107A1
Human necessities

Live attenuated oral vaccine against ETEC and typhoid fever

#7 | 2020-04-16
US20200113987A1
Human necessities

Infectious plasmodium sporozoites grown in vitro

#8 | 2018-09-20
US20180264099A1
Human necessities

Live attenuated oral vaccine against shigellosis and typhoid fever

#9 | 2018-06-14
US20180161413A1
Human necessities

Infectious plasmodium sporozoites grown in vitro

#10 | 2017-09-28
US20170274061A1
Human necessities

Purified plasmodium and vaccine compositions

#11 | 2016-10-06
US20160287688A1
Human necessities

Infectious plasmodium sporozoites grown in vitro

#12 | 2016-06-23
US20160175417A1
Human necessities

Purified plasmodium and vaccine compositions

#13 | 2016-06-09
US20160158351A1
Human necessities

Pharmaceutical compositions comprising attenuated sporozoites and glycolipid adjuvants

#14 | 2015-11-05
US20150313981A1
Human necessities

Purified plasmodium and vaccine compositions

#15 | 2014-05-01
US20140120138A1
Human necessities

Pharmaceutical compositions comprising attenuated sporozoites and glycolipid adjuvants

#16 | 2013-09-26
US20130251750A1
Human necessities

Purified and vaccine composition

#17 | 2013-08-29
US20130224250A1
Human necessities

Purified and vaccine composition

#18 | 2012-11-15
US20120288525A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING ATTENUATED PLASMODIUM SPOROZOITES AND GLYCOLIPID ADJUVANTS

#19 | 2012-08-02
US20120196289A1
Physics

NOVEL ASSAY FOR DETECTING IMMUNE RESPONSES INVOLVING ANTIGEN SPECIFIC CYTOKINE AND/OR ANTIGEN SPECIFIC CYTOKINE SECRETING T-CELLS

#20 | 2012-06-21
US20120156245A1
Human necessities

Methods for the Prevention of Malaria

#21 | 2012-03-08
US20120058543A1
Human necessities

Purified plasmodium and vaccine compositions

#22 | 2011-03-01
US9978669
-

Assay for detecting immune responses involving antigen specific cytokine and/or antigen specific cytokine secreting T-cells

#23 | 2010-07-22
US20100183680A1
Human necessities

Purified plasmodium and vaccine compositions

#24 | 2008-03-20
US20080069830A1
Chemistry; metallurgy

Dna Sequences, Peptides, Antibodies and Vaccines for Prevention and Treatment of Sars

#25 | 2007-07-19
US20070169209A1
Human necessities

Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production

#26 | 2006-08-24
US20060188527A1
Human necessities

Methods for vaccinating against malaria

#27 | 2005-10-06
US20050220822A1
Human necessities

Methods for the prevention of malaria

#28 | 2005-09-22
US20050208078A1
Human necessities

Methods for the prevention of malaria

#29 | 2005-05-12
US20050100532A1
Human necessities

Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production

InventorID:

413861 ⎘